6/05/2020 | Point of view

Impact of COVID-19 on Clinical Trials

 
 
 
Share
 

Many companies have paused or delayed scheduled clinical trials due to the Covid-19 emergency

Sarah Morgan, Liz O’Neil, and Karin Parks, our partners at Intouch Solutions, have analyzed the situation and discussed the challenges for the pharma industry to comply with protocol in existing trials and prevent that lifesaving treatments from reaching patients.

 

Download the PoV here

 

Read the full article at www.intouchsol.com

  • Client engagement
  • Clinical Trials
  • CORONAVIRUS
  • Customer Journey
  • Digital health
  • Digital health revolution
  • Digital Health Transformation
  • Healthcare